rs1241624179
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_015365.3(AMMECR1):c.844G>T(p.Ala282Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,095,066 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015365.3 missense
Scores
Clinical Significance
Conservation
Publications
- midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosisInheritance: XL Classification: STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae)
- Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMMECR1 | NM_015365.3 | c.844G>T | p.Ala282Ser | missense_variant | Exon 5 of 6 | ENST00000262844.10 | NP_056180.1 | |
AMMECR1 | NM_001025580.2 | c.733G>T | p.Ala245Ser | missense_variant | Exon 4 of 5 | NP_001020751.1 | ||
AMMECR1 | NM_001171689.2 | c.475G>T | p.Ala159Ser | missense_variant | Exon 7 of 8 | NP_001165160.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD2 exomes AF: 0.0000110 AC: 2AN: 182522 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1095066Hom.: 0 Cov.: 27 AF XY: 0.0000166 AC XY: 6AN XY: 361202 show subpopulations
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.844G>T (p.A282S) alteration is located in exon 5 (coding exon 5) of the AMMECR1 gene. This alteration results from a G to T substitution at nucleotide position 844, causing the alanine (A) at amino acid position 282 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at